Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Apr 04, 2022 7:30 AM - Apr 05, 2022 4:45 PM

(US Eastern Standard Time)

Global Labeling Conference

#LABELING22 HAS GONE FULLY VIRTUAL! Register by Friday, March 4 to take advantage of the Advance Rate savings and join us from the comfort of your home or office! Register Today

Session 6: Patient Centricity

Session Chair(s)

Kathleen  Salazar, MA, MBA

Kathleen Salazar, MA, MBA

Head, Global Labeling Implementation

Johnson & Johnson Innovative Medicine, United States

Rie  Matsui, RPh

Rie Matsui, RPh

Senior Director, Regional Labeling Head for APAC, International Labeling

Pfizer R&D Japan G.K., Japan

Pharmaceutical labeling contains important product information that helps enable appropriate prescribing decisions to be made, as well as the safe and effective use of prescribed products. With patients increasingly involved in their own healthcare decisions and outcomes, there is a need to develop patient-focused product information that is both understandable and accessible across a varied group of product end-users. This session will describe insights and approaches to creating patient centric pharmaceutical labeling and supporting development of health literacy across users of patient product information to help ensure engagement and understanding of patients who use our products.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe the opportunities and challenges of patient-centric drug labeling for all stakeholders
  • Describe best practices in developing and implementing patient-centric drug labeling
  • Describe the value of health literacy in creating effective patient-centered labeling

Speaker(s)

Meredith  Smith, PhD, MPA, FISPE

From Passive to Active: Patient-Centered Benefit-Risk Communication for Medicinal Products

Meredith Smith, PhD, MPA, FISPE

Evidera, Inc, United States

Senior Director, Implementation Science Pillar Lead

Kim  Quaintance-Lunn

Patient Centric Labels in the US – Are We There Yet?

Kim Quaintance-Lunn

Alexion, United States

Vice President, Head of Regulatory Science and Execution

Annlouise  R Assaf, PhD, MS, FISPE

Health Literacy: Educating Patients Beyond the Label Itself, Impact of Labeling Development

Annlouise R Assaf, PhD, MS, FISPE

Pfizer Inc, United States

Senior Director, Patient Health Activation Expert

Hayley  Parker, PhD, MSc

Focusing on Communication to the Patient: Australian and Canadian Patient Labeling

Hayley Parker, PhD, MSc

Pepgen Inc., United States

Senior Vice President

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.